Skip to content

Intensive dietary counseling in non alcoholic fatty liver disease

Efficacy of intensive dietary counseling on metabolic, anthropometric and ultrasound parameters among adult Indian Non alcoholic fatty liver disease (NAFLD) patients: A Randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013179
Enrollment
140
Registered
2018-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Clinically stable patients with Non Alcoholic Fatty Liver Disease

Interventions

Intervention1: Intensive dietary counseling along with standard care: 5 face to face and 4 telephonic dietary counseling sessions by a trained dietitian Control Intervention1: Standard therapy: NAFLD

Sponsors

NONE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with NAFLD in the age group of 18- 60 years attending the OPD 2. Willing to give written consent for participation in the study 3. Patients with BMI between 25-29.9kg/m2

Exclusion criteria

Exclusion criteria: 1. Alcohol intake >30gm/day in males or 20gm/day in females 2. Inability to attend follow-up session 3. Pregnant, lactating women or pregnancy anticipated during study 4. Diagnosed cases of Diabetes 5. Thyroid disease not controlled by medication 6. Already participating in a formal weight loss program or on medication to promote weight loss 7. Significant changes in diet and exercise habits in previous 3 months resulting in weight loss >5% of body weight. 8. Known cases of endocrine disorders including Cushingâ??s syndrome or history of long term steroid intake or any other secondary causes of fatty liver. 9. Known case of psychiatric illness

Design outcomes

Primary

MeasureTime frame
1) Change in CAP score in fibroscan after 6 months 2) Reduction of liver enzymes 3) Reduction in grade of steatosis through abdominal ultrasound 4) Reduction in 5% of the body weight among patients of NAFLD with normal liver enzymes and 10% of body weight among patients of NAFLD with raised liver enzymes 5) Reduction in waist circumference 6) Reduction in fat percentage through body composition analysis 7) Change in HOMA IR Timepoint: 3 and 6 months

Secondary

MeasureTime frame
noneTimepoint: none

Countries

India

Contacts

Public ContactDr Piyush Ranjan

AIIMS, New Delhi

drpiyushaiims@gmail.com9268714198

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026